Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders-Reference-Cited by-同舟云学术

Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders

Published:2015-07-06 Issue:7 Volume:10 Page:e0132032
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Moustafa Dina A.,Scarff Jennifer M.,Garcia Preston P.,Cassidy Sara K. B.,DiGiandomenico Antonio,Waag David M.,Inzana Thomas J.,Goldberg Joanna B.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference93 articles.

1. Bioterrorism, Glanders and melioidosis;AC Cheng;Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin,2005

2. Genomic diversity of Burkholderia pseudomallei clinical isolates: subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b;D DeShazer;J Bacteriol,2004

3. Current studies on the pathogenesis of melioidosis;DE Woods;Microbes Infect,1999

4. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia;BJ Currie;Trop Med Int Health,2004

5. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei;WJ Wiersinga;Nature Rev Microbiol,2006

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotype switching inPseudomonas aeruginosaST111 enhances adhesion and virulence;2024-04-26

2. Burkholderia pseudomallei Complex Subunit and Glycoconjugate Vaccines and Their Potential to Elicit Cross-Protection to Burkholderia cepacia Complex;Vaccines;2024-03-15

3. Burkholderia (Glanders and Melioidosis) Attack;Ciottone's Disaster Medicine;2024

4. Intranasal immunization with a Bucl8-based vaccine ameliorates bacterial burden and pathological inflammation, and promotes an IgG2a/b dominant response in an outbred mouse model of Burkholderia infection;Frontiers in Immunology;2023-07-20

5. Recent advances in lipopolysaccharide-based glycoconjugate vaccines;Expert Review of Vaccines;2021-10-25